The escalating prevalence of obesity worldwide poses a significant challenge to healthcare professionals. This complex, multifaceted condition requires a comprehensive, integrated approach to management, encompassing lifestyle modification, pharmacotherapy, and potentially, surgery.
The cornerstone of obesity management is lifestyle intervention, which incorporates dietary changes, physical activity, and behavior modification. A personalized approach, tailored to the patient's preferences and capabilities, is crucial for the success of this intervention. Multidisciplinary teams involving dietitians, physical therapists, and psychologists can provide valuable support.
Pharmacotherapy is an adjunct to lifestyle intervention and is indicated in patients with a BMI of 30 or above, or 27 and above in the presence of comorbidities. Several agents, including orlistat, liraglutide, and bupropion-naltrexone, have been approved for long-term use. These drugs should be used judiciously, considering their side-effect profiles and contraindications.
Bariatric surgery is considered in patients with severe obesity (BMI >40) or moderate obesity (BMI >35) with associated comorbidities. It offers substantial and sustained weight loss, along with improvements in obesity-related conditions. However, it carries surgical risks and necessitates lifelong medical follow-up and nutritional supplementation.
Emerging therapies in obesity management include novel pharmacological agents targeting various aspects of energy homeostasis, and minimally invasive procedures such as endoscopic sleeve gastroplasty. While promising, these therapies require further investigation to establish their safety and efficacy.
Effective obesity management demands a comprehensive, patient-centered strategy, encompassing lifestyle intervention, pharmacotherapy, and, where appropriate, surgery. Keeping abreast of emerging therapies is crucial to expanding our arsenal in the battle against this global health issue. The ultimate goal is to improve the quality of life and longevity of our patients.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation